Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 90, Issue , 2014, Pages 198-206

  Szeitz, András ^a   Manji, Jamil ^b   Riggs, K Wayne ^a   Thamboo, Andrew ^b   Javer, Amin R ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

Budesonide; Cortisol; Liquid chromatography mass spectrometry; Method validation; Plasma

Indexed keywords

BUDESONIDE; CHARCOAL; DEXAMETHASONE; HYDROCORTISONE; TERT BUTYL METHYL ETHER;

ARTICLE; CHROMATOGRAPHY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; EVALUATION STUDY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; ION TRAP MASS SPECTROMETRY; MASS SPECTROMETER; MEASUREMENT ACCURACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

BUDESONIDE; CORTISOL; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METHOD VALIDATION; PLASMA;

BUDESONIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIMIT OF DETECTION; PITUITARY-ADRENAL SYSTEM; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 84891430861     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.12.006     Document Type: Article

References (30)

1. Sachanandani N.S., Piccirillo J.F., Kramper M.A., Thawley S.E., Vlahiotis A. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch. Otolaryngol. Head Neck Surg. 2009, 135:303-307.
2. Poetker D.M., Reh D.D. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol. Clin. N. Am. 2010, 43:753-768.
3. Szefler S.J. Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid. J. Allergy Clin. Immunol. 1999, 104:175-183.
4. Passalacqua G., Albano M., Canonica G.W., Bachert C., Van Cauwenberge P., Davies R.J., Durham S.R., Kontou-Fili K., Horak F., Malling H.J. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000, 55:16-33.
5. Clark D.J., Grove A., Cargill R.I., Lipworth B.J. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996, 51:262-266.
6. Moller C., Ahlstrom H., Henricson K.A., Malmqvist L.A., Akerlund A., Hildebrand H. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin. Exp. Allergy 2003, 33:816-822.
7. Arioli F., Fidani M., Casati A., Fracchiolla M.L., Pompa G. Investigation on possible transformations of cortisol, cortisone and cortisol glucuronide in bovine faecal matter using liquid chromatography-mass spectrometry. Steroids 2010, 75:350-354.
8. Taylor P.J., van Rosendal S.P., Coombes J.S., Gordon R.D., Stowasser M. Simultaneous measurement of aldosterone and cortisol by high-performance liquid chromatography-tandem mass spectrometry: application to dehydration-rehydration studies. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2010, 878:1195-1198.
9. Ionita I.A., Fast D.M., Akhlaghi F. Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2009, 877:765-772.
10. Cuzzola A., Petri A., Mazzini F., Salvadori P. Application of hyphenated mass spectrometry techniques for the analysis of urinary free glucocorticoids. Rapid Commun. Mass Spectrom. 2009, 23:2975-2982.
11. Wang Y., Tang Y., Moellmann H., Hochhaus G. Simultaneous quantification of budesonide and its two metabolites, 6beta-hydroxybudesonide and 16alpha-hydroxyprednisolone, in human plasma by liquid chromatography negative electrospray ionization tandem mass spectrometry. Biomed. Chromatogr. 2003, 17:158-164.
12. Deventer K., Mikulcikova P., Van Hoecke H., Van Eenoo P., Delbeke F.T. Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2006, 42:474-479.
13. Qu J., Qu Y., Straubinger R.M. Ultra-sensitive quantification of corticosteroids in plasma samples using selective solid-phase extraction and reversed-phase capillary high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 2007, 79:3786-3793.
14. Algorta J., Pena M.A., Francisco S., Abajo Z., Sanz E. Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations. Trials 2008, 9:34.
15. Raaska K., Niemi M., Neuvonen M., Neuvonen P.J., Kivisto K.T. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Clin. Pharmacol. Ther. 2002, 72:362-369.
16. Clearie K.L., Williamson P.A., Meldrum K., Gillen M., Carlsson L.G., Carlholm M., Ekelund J., Lipworth B.J. Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide. Br. J. Clin. Pharmacol. 2011, 71:504-513.
17. Cui X., Shao B., Zhao R., Yang Y., Hu J., Tu X. Simultaneous determination of seventeen glucocorticoids residues in milk and eggs by ultra-performance liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:2355-2364.
18. Shao B., Cui X., Yang Y., Zhang J., Wu Y. Validation of a solid-phase extraction and ultra-performance liquid chromatographic tandem mass spectrometric method for the detection of 16 glucocorticoids in pig tissues. J. AOAC Int. 2009, 92:604-611.
19. Taylor R.L., Grebe S.K., Singh R.J. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin. Chem. 2004, 50:2345-2352.
20. FDA Guidance for Industry, Bioanalytical Method Validation, Rockville 2001, (accessed 20.11.13). http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidance/ucm070107.pdf.
21. Phillips K., Oborne J., Lewis S., Harrison T.W., Tattersfield A.E. Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax 2004, 59:26-30.
22. Cydulka R.K., Emerman C.L. Adrenal function and physiologic stress during acute asthma exacerbation. Ann. Emerg. Med. 1998, 31:558-561.
23. Dorin R.I., Qualls C.R., Crapo L.M. Diagnosis of adrenal insufficiency. Ann. Intern. Med. 2003, 139:194-204.
24. Zhang S.Q., Fan Y.M. Determination of andrograpolide sodium bisulphite in Beagle dog plasma by LC-MS/MS and its application to pharmacokinetics. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2012, 907:173-177.
25. Jusko W.J., Pyszczynski N.A., Bushway M.S., D'Ambrosio R., Mis S.M. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J. Chromatogr. B: Biomed. Appl. 1994, 658:47-54.
26. Difrancesco R., Frerichs V., Donnelly J., Hagler C., Hochreiter J., Tornatore K.M. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 859:42-51.
27. Kanowitz S.J., Batra P.S., Citardi M.J. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis. Otolaryngol. Head Neck Surg. 2008, 139:131-136.
28. Rudmik L., Soler Z.M., Orlandi R.R., Stewart M.G., Bhattacharyya N., Kennedy D.W., Smith T.L. Early postoperative care following endoscopic sinus surgery: an evidence-based review with recommendations. Int. Forum Allergy Rhinol. 2011, 1:417-430.
29. Bhalla R.K., Payton K., Wright E.D. Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression. J. Otolaryngol. Head Neck Surg. 2008, 37:821-825.
30. Thorsson L., Borga O., Edsbacker S. Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder. Br. J. Clin. Pharmacol. 1999, 47:619-624.